Institutional Owners May Ignore ARS Pharmaceuticals, Inc.'s (NASDAQ:SPRY) Recent US$67m Market Cap Decline as Longer-term Profits Stay in the Green

Yahoo FinanceDec 24 10:24 ET

ARS Pharmaceuticals Says Express Scripts Has Added Neffy (Epinephrine Nasal Spray) To Its Commercial National Formularies

BenzingaDec 19 17:29 ET

ARS Pharmaceuticals Announces Neffy (Epinephrine Nasal Spray) Is Available on Express Scripts Commercial National Formularies

GlobeNewswireDec 19 17:25 ET

ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 18 08:00 ET

Ars Pharmaceuticals Insider Sold Shares Worth $657,625, According to a Recent SEC Filing

MT NewswiresDec 12 17:47 ET

ARS Pharmaceuticals Files for Approval of Neffy in China, Japan and Australia

TipRanksDec 12 14:40 ET